TECH BUYER Dec 2020 - IDC Perspective - Doc # CA47068920

AI in Canadian Healthcare — The COVID-19 Perspective

By: Warren ShiauResearch Vice President, AI & Analytics

Abstract

This IDC Perspective discusses COVID-19's effect on AI spend in the Canadian healthcare system. Process- and workflow-specific AI solutions drive monetarily quantifiable benefits right now by utilizing the existing healthcare IT infrastructure. IDC believes that COVID-19 realities will drive Canadian healthcare IT investment toward operationally feasible and attractive process and workflow solutions. IDC expects healthcare AI spend to be concentrated on improving process and workflow in three primary areas: monitoring and diagnostics, clinical and patient data, and care intake and delivery (i.e., "digital front door" solutions).

"Development of a coordinated strategic approach to pandemic management incorporating mass public testing, data and tracking/tracing requirements, methods of obtaining data, privacy exemptions, data aggregation and management, analysis/modeling and use of AI, and other critical factors such as political support, free federal/interprovincial data flow, and funding is a prerequisite to any major pandemic-related AI spending boosts in Canada," says Warren Shiau, research vice president, Artificial Intelligence, IDC Canada.


Coverage

Content


Get More

When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.



Related Links

Do you have questions about this document
or available subscriptions?

Contact Us